Powerup Acquisition CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Aspire Biopharma Holdings, Inc. is holding a special meeting on June 9, 2026, to seek stockholder approval for warrant-related proposals, including the issuance of shares upon warrant exercise and adjustments to warrant terms.
Aspire Biopharma Holdings, Inc. calls a special meeting to approve a reverse stock split, significant share issuances for capital, and an increase in authorized common stock.
Aspire Biopharma Holdings, Inc. calls a Special Meeting to vote on a reverse stock split to maintain Nasdaq listing and approve the issuance of shares from convertible promissory notes.
PowerUp Acquisition Corp. is seeking shareholder approval to extend the deadline for completing a business combination and remove net tangible asset requirements to facilitate a merger with Visiox Pharmaceuticals, Inc.